New brain tumor subtypes discovery may help develop treatments for incurable brain cancer
Research led by RCSI University of Medicine and Health Sciences in Ireland has discovered three…
December 6, 2022 - 2 minutes
Cancer: Keep up to Date with the Latest in Oncology
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
Show More
Editor's Picks for Cancer
- A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
- Immuno-Oncology: From Science Fiction to the Mainstream
- ADC Approval Buoys Spirits in Cancer Treatment Space
- Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
- Meet 20 European Immuno-Oncology Companies that are Fighting Cancer
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportLatest Cancer Articles
ImaginAb launching clinical trial for renal cancer and malignant melanoma
ImaginAb Inc., which is focused on developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET) imaging agent and…
December 6, 2022 - 3 minutes
Startup Graegis developing therapies for radiation side-effects
Graegis Pharmaceuticals, a startup developing new therapies aimed at preventing the side effects of radiotherapies,…
December 6, 2022 - 2 minutes
New company Liminatus Pharma Inc to develop three cancer treatments
Clinical-stage biopharma company Liminatus Pharma LLC and Iris Acquisition Corp, a publicly traded special purpose…
December 5, 2022 - 3 minutes
Singapore researchers develop affordable cancer testing method
Scientists from the National University of Singapore (NUS) have discovered a novel low-cost method of…
December 5, 2022 - 4 minutes
Faron Pharmaceuticals provides cancer treatment update
Faron Pharmaceuticals Oy has given an update on its phase I/II BEXMAB study, investigating bexmarilimab.…
December 5, 2022 - 2 minutes
Sponsored
by Champions Oncology
Deciphering blood cancer complexity with multi-omics and patient-relevant disease models
A new case of blood cancer gets diagnosed approximately every three minutes in Western countries.…
December 5, 2022 - 7 minutes
Partnership to deliver oncology workflow for 7 European hospitals
A BC Platforms (BCP) partnership that includes Finland’s Euformatics and Hungary’s Oncompass Medicine has been…
December 2, 2022 - 4 minutes
Full-Life Technologies acquiring Focus-X Therapeutics
Full-Life Technologies, a global radiotherapeutics company, is acquiring New Jersey-based Focus-X Therapeutics, a company developing…
December 2, 2022 - 2 minutes
Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2
Netherlands-based ISA Pharmaceuticals B.V., has announced that it has completed enrolment in its phase 2…
December 1, 2022 - 2 minutes
SOTIO exercises option on ADC program
SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, has exercised its first…
November 30, 2022 - 2 minutes
AstraZeneca splashes out up to $320M on T-cell receptor therapy company
Neogene Therapeutics, Inc., a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of…
November 30, 2022 - 3 minutes
